from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2969c/-

LFCtreatmentdescriptionclass of inhibitor

-0.653

Amikacinug/mL Amikacintranslation

-1.005

Cap5-10ug/mL Capreomycintranslation

-1.524

Rox10-50 ug/mL Roxithromycintranslation

0.501

SM2-5 ug/mL Streptomycintranslation

-1.411

Tet5-10 ug/mL Tetracyclinetranslation

0.609

Rif0.2-5ug/mL Rifampicintranscription

-0.066

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.135

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.329

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.599

CPZ10-50 ug/mL Chlorpromazinerespiration

0.666

Clofazimine10-13 ug/mL Clofaziminerespiration

0.574

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.539

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.087

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.332

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.900

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.162

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.893

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.045

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.358

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.655

KCN5-20 ug/mL Potassium cyaniderespiration

0.034

NaN30.2-2 mM Sodium aziderespiration

-0.024

Nigericin50 uM Nigericinrespiration

-0.140

TRC10-150 ug/mL Triclosanrespiration

0.294

TRZ10-25 ug/mL Thioridazinerespiration

-1.262

Valinomycin0.5-10 uM Valinomycinrespiration

-0.467

ZnSO42 mM ZnSO4respiration

0.471

menadione6-10 ug/mL Menadionerespiration

0.627

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.524

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.154

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.470

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.350

NRP_1Non-replicating persistence stage 1dosRassociated

-0.033

Amp0.2mg/mL AmpicillincellWall

0.309

Cephalexin20-100 ug/mL CephalexincellWall

0.093

Cerulenin0.32-5 ug/mL CerulenincellWall

0.455

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.170

EMB10-20 ug/mL EthambutolcellWall

0.550

Eta12-40 ug/mL EthionamidecellWall

0.517

INH0.2-0.4 ug/mL IsoniazidcellWall

0.593

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.105

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.320

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.415

BZA0.12 mg/mL BenzamidearomaticAmides

-0.693

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.927

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.365

H2O24 mM hydrogen peroxideDNAdamaging

-0.229

Levo10 ug/mL LevofloxacinDNAdamaging

-0.519

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.807

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.682

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.258

UVUV-irradiationDNAdamaging

1.068

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.204

Antimycin12.5-50 ug/mL Antimycin A?

0.039

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.641

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.016

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.113

PA8240.2-2 ug/mL PA-824?

0.055

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.106

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.573

Verapamil50 uM Verapamil?

0.680

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.245

methoxatin10-20 ug/mL Methoxatin?